The Latest Cardiac and Vascular News
SILVER SPRING, Md., May 04, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the three months ended March 31, 2021. Recent Highlights Recorded […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Verve Therapeutics, a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that Sheila Mikhail, J.D., MBA, chief executive officer and co-founder of Asklepios BioPharmaceutical, Inc. (AskBio), a subsidiary of Bayer AG, has joined the company’s board of […]
2021 Q1 HIGHLIGHTS compared to the corresponding period of 2020: – Revenues were $13.2 million, an increase of 40% – Pre-tax net income of $6.0 million, an increase of $2.5 million, or 74%, compared to $3.5 million – Net income was $4.9 million, or $0.73 per basic share and $0.60 […]
WESTMINSTER, Colo., May 03, 2021 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced C. Jeff Dekker as its Chief Financial Officer, effective May 10, 2021, following Brian Selby’s planned departure after 14 years of […]
SOUTH SAN FRANCISCO, Calif., May 03, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on April 30, 2021 it granted stock options to purchase an aggregate of 69,800 shares of common stock to six new employees whose employment commenced in April 2021 as a material inducement to […]
Preliminary Results Demonstrate Continued Strong Demand for Owlet’s Growing Connected Ecosystem Product and Service Suite Net revenues estimated to be $21.5M-$22.0M, a 45-48% increase from Q1 2020. Gross margin estimated to be 57-58%, a 1,000-1,100 basis point increase from Q1 2020. Recent announcements of new additions to the Board of […]
Dr. Ben Carson Sr. has joined the Board of Directors of HeartStitch® Inc. FOUNTAIN VALLEY, Calif., May 3, 2021 /PRNewswire/ — HeartStitch® has announced the appointment of a renowned Neurosurgeon and former Secretary of the US Department of Housing and Urban Development to its Board of Directors. Dr. Carson will fill the seat […]
Medical device company Occlutech Holding AG, one of the world´s leading providers of minimally invasive structural heart disease devices, announces the election of four new members to the board SCHAFFHAUSEN, Switzerland, May 3, 2021 /PRNewswire/ — Occlutech Holding AG (“Occlutech”) today announces that Marianne Dicander Alexandersson, Mette-Marie Harild, Helena Levander, and Michel Lussier have been elected as […]
WAYNE, Pa., May 03, 2021 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 15, 2021 to shareholders of record at the close of business on […]
Ghent, Belgium, 3 May 2021 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces in accordance with Article 15 of the Belgian Act of 2 May 2007 on the disclosure of major participations in […]
